Search
Markets
Watchlist
News
Analysis
Tools
Stock Screener
Scan to Download
One powerful score. Smarter investment decisions.
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
Log in
Start for free
Search
Start for free
Markets
/
Stocks
/
abus
/
Arbutus Biopharma Corp
ABUS
Add to Watchlist
4.340
USD
-0.070
-1.59%
Close 07-31 16:00(ET)
Quotes delayed by 15 min
0.000
USD
0.000
Pre-market 08/03, 09:30 (ET)
857.31M
Market Cap
5.23
P/E TTM
Arbutus Biopharma Corp
4.340
-0.070
-1.59%
Overview
Financials
Discussions
Analysis
Company
Profile
Revenue
Shareholders
Corporate
Overview
Financials
Discussions
Analysis
Company
Profile
Revenue
Shareholders
Corporate
Shareholding Stats
Updated: Sun, May 10
Updated: Sun, May 10
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Roivant Sciences Ltd.
19.73%
Morgan Stanley Investment Management Inc. (US)
13.01%
Whitefort Capital Management, LP
8.02%
Two Seas Capital LP
6.39%
BlackRock Institutional Trust Company, N.A.
5.88%
Other
46.98%
Shareholders
Shareholders
Proportion
Roivant Sciences Ltd.
19.73%
Morgan Stanley Investment Management Inc. (US)
13.01%
Whitefort Capital Management, LP
8.02%
Two Seas Capital LP
6.39%
BlackRock Institutional Trust Company, N.A.
5.88%
Other
46.98%
Shareholder Types
Shareholders
Proportion
Hedge Fund
24.34%
Investment Advisor/Hedge Fund
22.12%
Corporation
19.73%
Investment Advisor
16.48%
Research Firm
3.19%
Individual Investor
0.82%
Bank and Trust
0.33%
Pension Fund
0.20%
Insurance Company
0.02%
Other
12.77%
Institutional Shareholding
Updated: Wed, Apr 1
Updated: Wed, Apr 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q1
317
128.81M
65.56%
+6.75M
2025Q4
303
120.46M
63.27%
+16.91K
2025Q3
308
120.41M
63.81%
+205.66K
2025Q2
303
120.18M
60.87%
+6.31M
2025Q1
305
113.89M
56.48%
+5.73M
2024Q4
291
105.12M
56.03%
+2.81M
2024Q3
289
102.16M
54.67%
+4.63M
2024Q2
265
97.30M
48.54%
+13.53M
2024Q1
263
83.76M
49.95%
-6.24M
2023Q4
266
79.35M
51.53%
+6.48M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Roivant Sciences Ltd.
38.85M
19.87%
--
--
Feb 25, 2025
Morgan Stanley Investment Management Inc. (US)
25.62M
13.11%
+2.30M
+9.87%
Dec 31, 2025
Whitefort Capital Management, LP
13.34M
6.83%
--
--
Dec 31, 2025
Two Seas Capital LP
12.59M
6.44%
+1.60M
+14.54%
Dec 31, 2025
BlackRock Institutional Trust Company, N.A.
11.57M
5.92%
+292.37K
+2.59%
Dec 31, 2025
State Street Investment Management (US)
5.91M
3.02%
+1.81M
+44.16%
Dec 31, 2025
Adar1 Capital Management LLC
5.42M
2.77%
+2.51M
+86.52%
Dec 31, 2025
Adage Capital Management, L.P.
4.34M
2.22%
-675.00K
-13.46%
Dec 31, 2025
Geode Capital Management, L.L.C.
3.68M
1.88%
+11.14K
+0.30%
Dec 31, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
Virtus LifeSci Biotech Clinical Trials ETF
0.89%
Invesco NASDAQ Future Gen 200 ETF
0.69%
Hypatia Women CEO ETF
0.28%
iShares Micro-Cap ETF
0.14%
iShares MSCI USA Small-Cap Min Vol Factor ETF
0.11%
ProShares Ultra Nasdaq Biotechnology
0.09%
Invesco Nasdaq Biotechnology ETF
0.08%
iShares ESG Aware MSCI USA Small-Cap ETF
0.07%
State Street SPDR S&P Biotech ETF
0.06%
iShares Biotechnology ETF
0.06%
View more
Virtus LifeSci Biotech Clinical Trials ETF
Proportion
0.89%
Invesco NASDAQ Future Gen 200 ETF
Proportion
0.69%
Hypatia Women CEO ETF
Proportion
0.28%
iShares Micro-Cap ETF
Proportion
0.14%
iShares MSCI USA Small-Cap Min Vol Factor ETF
Proportion
0.11%
ProShares Ultra Nasdaq Biotechnology
Proportion
0.09%
Invesco Nasdaq Biotechnology ETF
Proportion
0.08%
iShares ESG Aware MSCI USA Small-Cap ETF
Proportion
0.07%
State Street SPDR S&P Biotech ETF
Proportion
0.06%
iShares Biotechnology ETF
Proportion
0.06%